William J. Link Ph.D., Director at Tarsus Pharmaceuticals, Inc. (TARS), sold 12,500 shares at $61.97 ($776K) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($776k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.97 | 10,572 | $655K | 84.4% |
| 2 | $62.94 | 1,928 | $121K | 15.6% |
| Total | $62.12 avg | 12,500 | $776K | 100% |
| Filing → |
| TARS | SELL | 2025-12-17 | $3.3M | — | Filing → |
| TARS | SELL | 2025-09-10 | $1.5M | — | Filing → |
| TARS | SELL | 2024-08-14 | $1.8M | — | Filing → |